The Detroit Tigers went into the offseason largely healthy despite the crushing playoff exit, however you never know what you will get when players report for spring training. Such was the case with ...

From creating one monster to killing another, Christoph Waltz’s winter has been a horror show. The 69-year-old Austrian Oscar winner played Henrich Harlander, Victor Frankenstein’s wealthy benefactor, ...

More antibodies take aim at seeded propagation. New data ties tangle location to deficits in specific cognitive domains. Three first-in-human studies for antibodies targeting different parts of tau ...

Silevertinib shows robust antitumor and CNS activity in NSCLC patients with nonclassical EGFR mutations, achieving a 60% ORR and 86% CNS ORR. The disease control rate is 91%, with manageable adverse ...

MONTREAL--(BUSINESS WIRE)--Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in ...

The biggest stories of the day delivered to your inbox.

And the National Guard: coming to a city near you? After two brutal years of war, there is finally hope for a lasting peace in Gaza. Greg Myre in Tel Aviv explains why things start to get a lot more ...

In seven years New Yorkers will get three new Q line stations along Second Avenue in Harlem. That’s, of course, if things go according to the Metropolitan Transportation Authority’s plans. That was ...

Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, ...

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized ...